Pharma companies are committed to using electronic data capture in clinical trials. Technology adoption will continue to grow, as FDA and consumers want faster safety data.
Paul Bleicher
Advertisement
Paul Bleicher, MD, PhD, is chairman and chief scientific officer for Phase Forward.
Articles by Paul Bleicher
Advertisement
Latest Updated Articles
Tools Are Just the BeginningPublished: June 1st 2005 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics
2
Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform
3
AstraZeneca to Announce Deal with Trump Administration: Report
4
FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma
5
